The potential societal benefit of eliminating the opioid crisis exceeds $95 billion per year
The negative impacts of the opioid epidemic are substantial and increasing rapidly over time. No part of society—including households, governments, and the private sector—is safe from the devastation brought on by this national crisis. Read more from our report on epidemic, including productivity impacts, health care costs, public service costs, and non-monetized impacts.
More DetailsMichigan Syndromic Surveillance System (MSSS)
Syndromic surveillance detects unusual or sudden increases in patients reporting symptoms that could signal public health threats—providing states with an early warning before diagnoses are available.
More DetailsReframing Optimal Management of Pain and Opioids in Older Adults (ROMPO)
A pain management initiative focusing on older adults in primary care.
More DetailsThe Altarum Consumer Engagement (ACE) Measure
How do you measure patient engagement? Altarum's scientifically-validated survey tool captures a full patient profile with just 12 questions—in less than two minutes.
More DetailsHelping FDA Inform Patients and Providers About Biosimilar Treatment Options
A full-service strategic communications and marketing agency, and an Altarum subsidiary, Palladian Partners works on some of the toughest and most urgent issues in health and science.
More Details